Updated Meta-Analysis: Effects of Different Weight-Loss Medications on Fat Distribution

As one of the most prevalent health problems worldwide, obesity imposes substantial public health and economic burdens, which have attracted increasing attention from patients, regulatory agencies, and biopharmaceutical companies.Currently, research and development efforts are actively exploring weight‑loss medications targeting different pathways in the pathophysiology of obesity.Although various anti‑obesity or glucose‑lowering agents have been widely used […]

New Insulin Pumps and Hybrid Closed-Loop Systems: Toward “Automated Glycemic Control”

Recently, a review article by the team led by Professors Guo Lixin and Pan Qi from Beijing Hospital was published in the journal Aging Med (Milton), interpreting the Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition). The review focuses on the principles, clinical benefits, and application challenges of relevant […]

Needle-Free Insulin Injection: A New Approach to Reducing Pain and Psychological Resistance

Recently, a review article by the team led by Professors Guo Lixin and Pan Qi from Beijing Hospital was published in the journal Aging Med (Milton), interpreting the Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition). The review focuses on the principles, clinical benefits and application challenges of relevant […]

Key Progress in Anti-Inflammatory Therapy for CKM Syndrome

At the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases (Season 1, Quanzhou), Dr. Lin Chu of Peking University People’s Hospital emphasized that anti-inflammatory therapy carries important clinical value. However, it should not be used as an isolated intervention. Instead, it should be deeply integrated with standard treatments such as […]

Why Has Anti-Inflammatory Therapy Become a New Target in the Treatment of CKM?

At the 2025 Peking University Diabetes Forum & Coastal Long Bridge Symposium on Metabolic Diseases (Season 1, Quanzhou), Dr. Lin Chu of Peking University People’s Hospital pointed out that anti-inflammatory therapy has important clinical value, aiming to provide a reference for clinical practice.In 2023, the President of the American Heart Association (AHA) formally proposed the […]

Residual Islet Function Still Exists in Patients with Long-Duration T1DM

During the 2025 Peking University Diabetes Forum and Coastal Long Bridge Symposium on Metabolic Diseases,Professor Gu Nan from the Department of Endocrinology, Peking University First Hospital, delivered a report on the current status and challenges of insulin therapy for type 1 diabetes mellitus (T1DM).Insulin replacement therapy is the core treatment for T1DM, but its clinical […]

Two Phase III Studies of Mazdutide Published in Nature

Recently, the results of two Phase III clinical studies (DREAMS-1 and DREAMS-2) of mazdutide in Chinese patients with type 2 diabetes mellitus (T2DM) have been jointly published in the prestigious journal Nature.Following presentations at the Scientific Sessions of the American Diabetes Association (ADA) and the Annual Meeting of the European Association for the Study of […]

Improving Obesity Diagnosis and Treatment to Ultimately Enhance Patients’ Overall Health Outcomes

Modern medicine is gradually shifting from a disease-centered to a patient-centered holistic management model.In the face of complex chronic diseases such as obesity, traditional single-discipline diagnosis and treatment can no longer meet clinical needs, and a shift toward multidisciplinary collaborative “team-based care” is essential.This is not a simple return to general practice, but an organic […]